Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merrell Pharmaceuticals is a pharmaceutical company that currently operates as a subsidiary of the global healthcare leader Sanofi. With roots dating back to the establishment of the Wm. S. Merrell Chemical Company in 1828, the firm has a storied history in the American drug industry, including its time as Merrell Dow Pharmaceuticals and Marion Merrell Dow. The company is well-known for the development of significant legacy products such as the antihistamine Allegra (fexofenadine) and the gastrointestinal medication Bentyl. Following a series of mergers, it was eventually integrated into the Sanofi organization, where its expertise and product lines continue to contribute to a diverse therapeutic portfolio. Today, the entity primarily serves as a legal and brand component within Sanofi's broader operations in immunology, oncology, and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merrell Pharmaceuticals.